🔗 Permalink

Inventor profile of:

Pascal SCHNEIDER

City:

Epalinges

Country:

Switzerland

Published Applications:

Last publication date:

2020-03-26

Top Assignees for applications by Pascal SCHNEIDER

The entities that hold a legal rights for patent applications filed by inventor SCHNEIDER Pascal:

TOPOTARGET SWITZERLAND SA 8 Lausanne, Switzerland
Biogen Idec MA Inc. 5 Cambridge, MA United States
EDIMER PHARMACEUTICALS, INC. 3 Cambridge, MA United States
Apoxis S.A. 3 Epalinges, Switzerland
BIOGEN MA INC. 3 Cambridge, MA United States
UNIVERSITE DE LAUSANNE 2 Lausanne, Switzerland
EDIMER PHARMACEUTICALS, INC 2 Andover, MA United States
Apotech Research and Development Ltd. 1 , Switzerland
Edimer Biotech S.A. 1 Epalinges, Switzerland
APOTECH RESEARCH AND DEVELOPMENT LIMITED 1 Geneva, Switzerland
ESPOIRXLHED SÀRL 1 Geneva, Switzerland
Biogen Idcc MA Inc. 1 Cambridge, MA United States
Apotech Research and Development Ltd. 1 Geneva, Switzerland
Apoxis SA 1 Epalingee, Switzerland

Recent patent applications by SCHNEIDER Pascal

Pascal SCHNEIDER from Epalinges, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-26

US20200095305A1

Chemistry; metallurgy

METHODS OF MODULATING IMMUNE RESPONSES USING BCMA POLYPEPTIDE

#2 | 2018-09-27

US20180273605A1

Chemistry; metallurgy

Methods of modulating immune responses using BCMA polypeptide

#3 | 2018-06-21

US20180169188A1

Human necessities

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

#4 | 2016-09-22

US20160272694A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECTODERMAL DYSPLASIA

#5 | 2016-06-30

US20160184393A1

Human necessities

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

#6 | 2016-03-17

US20160075789A1

Chemistry; metallurgy

Anti-ectodysplasin antibodies

#7 | 2015-08-06

US20150218247A1

Chemistry; metallurgy

TACI AS AN ANTI-TUMOR AGENT

#8 | 2015-05-21

US20150139992A1

Chemistry; metallurgy

Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)

#9 | 2015-04-09

US20150098944A1

Chemistry; metallurgy

FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS

#10 | 2015-01-15

US20150017161A1

Chemistry; metallurgy

Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonist

#11 | 2015-01-01

US20150004129A1

Chemistry; metallurgy

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#12 | 2013-11-07

US20130295093A1

Human necessities

Pharmaceutical composition comprising EDA-1 Fusion Protein

#13 | 2013-10-17

US20130273046A1

Human necessities

Preparation of isolated agonist anti-EDAR monoclonal antibodies

#14 | 2013-08-08

US20130202552A1

Chemistry; metallurgy

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#15 | 2012-08-23

US20120214687A1

Chemistry; metallurgy

Methods of screening for a compound that inhibits the interaction between BAFF and BCMA

#16 | 2012-07-26

US20120192296A1

Chemistry; metallurgy

Preparation of isolated agonist anti-EDAR monoclonal antibodies

#17 | 2012-07-26

US20120189634A1

Chemistry; metallurgy

TACI AS AN ANTI-TUMOR AGENT

#18 | 2012-01-12

US20120009211A1

Human necessities

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#19 | 2010-10-07

US20100254984A1

Human necessities

Treatment of ectodermal dysplasia with EDA1 fusion proteins

#20 | 2010-09-16

US20100233179A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#21 | 2009-02-26

US20090053252A1

Human necessities

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#22 | 2008-06-10

US10185425

Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins

#23 | 2007-10-02

US10115192

Methods of treating a tumor that expresses APRIL by administering BCMA

#24 | 2006-08-01

US10077438

Methods of treatment by administering an anti-BCMA antibody

#25 | 2006-04-13

US20060079457A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#26 | 2005-11-17

US20050255547A1

Chemistry; metallurgy

Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same

#27 | 2005-08-04

US20050169924A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#28 | 2005-07-14

US20050152872A1

Human necessities

Fusion constructs containing active sections on TNF ligands

#29 | 2005-05-12

US20050100548A1

Chemistry; metallurgy

BAFF, inhibitors thereof and their use in the modulation of B-cell response

#30 | 2005-03-22

US9911777

BAFF, inhibitors thereof and their use in the modulation of B-cell response

InventorID:

376230 ⎘